Abstract
Hospital-acquired aspergillosis is usually associated with environmental contamination. In 2015, continuous monitoring of airborne fungi and multilocus variable-number tandem-repeat analysis identified the source of Aspergillus fumigatus as the airway of a patient. Therefore, patients colonized with Aspergillus spp. should be treated in airborne infection isolation rooms.
Keywords:
Aspergillus fumigatus; France; airborne contamination; aspergillosis; fungi; hospital infections; intensive care units.
MeSH terms
-
Air Microbiology
-
Amphotericin B / therapeutic use
-
Antifungal Agents / therapeutic use
-
Aspergillosis / diagnosis*
-
Aspergillosis / drug therapy
-
Aspergillosis / microbiology
-
Aspergillosis / pathology
-
Aspergillus fumigatus / classification
-
Aspergillus fumigatus / drug effects
-
Aspergillus fumigatus / genetics*
-
Aspergillus fumigatus / isolation & purification
-
Cross Infection / diagnosis*
-
Cross Infection / drug therapy
-
Cross Infection / microbiology
-
Cross Infection / pathology
-
Fatal Outcome
-
Genotype*
-
Humans
-
Male
-
Middle Aged
-
Multilocus Sequence Typing
-
Patient Isolation
-
Tandem Repeat Sequences
Substances
-
Antifungal Agents
-
liposomal amphotericin B
-
Amphotericin B